Cargando…
Regen med therapeutic opportunities for fighting COVID‐19
This perspective from a Regenerative Medicine Manufacturing Society working group highlights regenerative medicine therapeutic opportunities for fighting COVID‐19. This article addresses why SARS‐CoV‐2 is so different from other viruses and how regenerative medicine is poised to deliver new therapeu...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461298/ https://www.ncbi.nlm.nih.gov/pubmed/32856432 http://dx.doi.org/10.1002/sctm.20-0245 |
_version_ | 1783576737484898304 |
---|---|
author | Atala, Anthony Henn, Alicia Lundberg, Martha Ahsan, Taby Greenberg, Jordan Krukin, Jeff Lynum, Steven Lutz, Cat Cetrulo, Kyle Albanna, Mohammad Pereira, Taciana Eaker, Shannon Hunsberger, Joshua |
author_facet | Atala, Anthony Henn, Alicia Lundberg, Martha Ahsan, Taby Greenberg, Jordan Krukin, Jeff Lynum, Steven Lutz, Cat Cetrulo, Kyle Albanna, Mohammad Pereira, Taciana Eaker, Shannon Hunsberger, Joshua |
author_sort | Atala, Anthony |
collection | PubMed |
description | This perspective from a Regenerative Medicine Manufacturing Society working group highlights regenerative medicine therapeutic opportunities for fighting COVID‐19. This article addresses why SARS‐CoV‐2 is so different from other viruses and how regenerative medicine is poised to deliver new therapeutic opportunities to battle COVID‐19. We describe animal models that depict the mechanism of action for COVID‐19 and that may help identify new treatments. Additionally, organoid platforms that can recapitulate some of the physiological properties of human organ systems, such as the lungs and the heart, are discussed as potential platforms that may prove useful in rapidly screening new drugs and identifying at‐risk patients. This article critically evaluates some of the promising regenerative medicine‐based therapies for treating COVID‐19 and presents some of the collective technologies and resources that the scientific community currently has available to confront this pandemic. |
format | Online Article Text |
id | pubmed-7461298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74612982020-09-02 Regen med therapeutic opportunities for fighting COVID‐19 Atala, Anthony Henn, Alicia Lundberg, Martha Ahsan, Taby Greenberg, Jordan Krukin, Jeff Lynum, Steven Lutz, Cat Cetrulo, Kyle Albanna, Mohammad Pereira, Taciana Eaker, Shannon Hunsberger, Joshua Stem Cells Transl Med Perspectives This perspective from a Regenerative Medicine Manufacturing Society working group highlights regenerative medicine therapeutic opportunities for fighting COVID‐19. This article addresses why SARS‐CoV‐2 is so different from other viruses and how regenerative medicine is poised to deliver new therapeutic opportunities to battle COVID‐19. We describe animal models that depict the mechanism of action for COVID‐19 and that may help identify new treatments. Additionally, organoid platforms that can recapitulate some of the physiological properties of human organ systems, such as the lungs and the heart, are discussed as potential platforms that may prove useful in rapidly screening new drugs and identifying at‐risk patients. This article critically evaluates some of the promising regenerative medicine‐based therapies for treating COVID‐19 and presents some of the collective technologies and resources that the scientific community currently has available to confront this pandemic. John Wiley & Sons, Inc. 2020-08-27 /pmc/articles/PMC7461298/ /pubmed/32856432 http://dx.doi.org/10.1002/sctm.20-0245 Text en © 2020 The Authors. stem cells translational medicine published by Wiley Periodicals LLC on behalf of AlphaMed Press. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Perspectives Atala, Anthony Henn, Alicia Lundberg, Martha Ahsan, Taby Greenberg, Jordan Krukin, Jeff Lynum, Steven Lutz, Cat Cetrulo, Kyle Albanna, Mohammad Pereira, Taciana Eaker, Shannon Hunsberger, Joshua Regen med therapeutic opportunities for fighting COVID‐19 |
title | Regen med therapeutic opportunities for fighting COVID‐19 |
title_full | Regen med therapeutic opportunities for fighting COVID‐19 |
title_fullStr | Regen med therapeutic opportunities for fighting COVID‐19 |
title_full_unstemmed | Regen med therapeutic opportunities for fighting COVID‐19 |
title_short | Regen med therapeutic opportunities for fighting COVID‐19 |
title_sort | regen med therapeutic opportunities for fighting covid‐19 |
topic | Perspectives |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7461298/ https://www.ncbi.nlm.nih.gov/pubmed/32856432 http://dx.doi.org/10.1002/sctm.20-0245 |
work_keys_str_mv | AT atalaanthony regenmedtherapeuticopportunitiesforfightingcovid19 AT hennalicia regenmedtherapeuticopportunitiesforfightingcovid19 AT lundbergmartha regenmedtherapeuticopportunitiesforfightingcovid19 AT ahsantaby regenmedtherapeuticopportunitiesforfightingcovid19 AT greenbergjordan regenmedtherapeuticopportunitiesforfightingcovid19 AT krukinjeff regenmedtherapeuticopportunitiesforfightingcovid19 AT lynumsteven regenmedtherapeuticopportunitiesforfightingcovid19 AT lutzcat regenmedtherapeuticopportunitiesforfightingcovid19 AT cetrulokyle regenmedtherapeuticopportunitiesforfightingcovid19 AT albannamohammad regenmedtherapeuticopportunitiesforfightingcovid19 AT pereirataciana regenmedtherapeuticopportunitiesforfightingcovid19 AT eakershannon regenmedtherapeuticopportunitiesforfightingcovid19 AT hunsbergerjoshua regenmedtherapeuticopportunitiesforfightingcovid19 |